Are you having problems with your bladder? There may be a more profound cause for the suffering than a random nuisance. The ...

For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

Frequent urination often signals underlying health conditions that require medical attention. While occasional increases in ...

for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

There is a wide range of variability with how often one should pee, particularly in regard to what’s “normal.” Learn if you ...

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...

Oct. 15, 2024 — A team tests the protective effect of a fermented black garlic extract against inflammation and the progression of prostate cancer in a study conducted on human prostate cancer ...

Before trying bedwetting alarms or prescription medications, bladder training exercises might be a useful first step to treat problematic bedwetting. If the problem does not resolve, consider getting ...

According to a release, the new deal will see a reduction in franchise payables with Riot Games eliminating $2m (~£1.57m) that was due in 2025. OverActive Media noted that the new agreement will give ...

Boston Scientific Corporation today announced the close of its acquisition of Axonics, Inc. , a medical technology company focused on the development and commercialization of differentiated devices to ...

Vance said of psychedelic treatments. Overall, experts agree that there is an abundance of uncertainties when it comes to the future of prescription drugs under the upcoming Trump administration.